157 related articles for article (PubMed ID: 23828278)
1. Limited detection of IgH gene rearrangements in plasma of patients with primary central nervous system lymphoma.
He J; Wu J; Jiao Y; Rodriguez FJ; Blakeley JO; Kinzler KW; Papadopoulos N; Vogelstein B; Holdhoff M
J Neurooncol; 2013 Sep; 114(3):275-9. PubMed ID: 23828278
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel recurrent ETV6-IgH fusions in primary central nervous system lymphoma.
Bruno A; Labreche K; Daniau M; Boisselier B; Gauchotte G; Royer-Perron L; Rahimian A; Lemoine F; de la Grange P; Guégan J; Bielle F; Polivka M; Adam C; Meyronet D; Figarella-Branger D; Villa C; Chrétien F; Eimer S; Davi F; Rousseau A; Houillier C; Soussain C; Mokhtari K; Hoang-Xuan K; Alentorn A
Neuro Oncol; 2018 Jul; 20(8):1092-1100. PubMed ID: 29432597
[TBL] [Abstract][Full Text] [Related]
3. Genetic evidence implies that primary and relapsed tumors arise from common precursor cells in primary central nervous system lymphoma.
Hattori K; Sakata-Yanagimoto M; Kusakabe M; Nanmoku T; Suehara Y; Matsuoka R; Noguchi M; Yokoyama Y; Kato T; Kurita N; Nishikii H; Obara N; Takano S; Ishikawa E; Matsumura A; Muratani M; Hasegawa Y; Chiba S
Cancer Sci; 2019 Jan; 110(1):401-407. PubMed ID: 30353605
[TBL] [Abstract][Full Text] [Related]
4. Novel diagnostic biomarker for patients with Non-Hodgkin's Lymphoma by IgH gene rearrangement.
Bo J; Sun L; Wang W; Ma C; Li H; Zhao Y
J Cancer Res Ther; 2016; 12(2):903-8. PubMed ID: 27461672
[TBL] [Abstract][Full Text] [Related]
5. IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patients.
He J; Wu J; Jiao Y; Wagner-Johnston N; Ambinder RF; Diaz LA; Kinzler KW; Vogelstein B; Papadopoulos N
Oncotarget; 2011 Mar; 2(3):178-85. PubMed ID: 21399237
[TBL] [Abstract][Full Text] [Related]
6. Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas.
Pott C; Tiemann M; Linke B; Ott MM; von Hofen M; Bolz I; Hiddemann W; Parwaresch R; Kneba M
Leukemia; 1998 Oct; 12(10):1630-7. PubMed ID: 9766510
[TBL] [Abstract][Full Text] [Related]
7. Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course.
Cady FM; O'Neill BP; Law ME; Decker PA; Kurtz DM; Giannini C; Porter AB; Kurtin PJ; Johnston PB; Dogan A; Remstein ED
J Clin Oncol; 2008 Oct; 26(29):4814-9. PubMed ID: 18645192
[TBL] [Abstract][Full Text] [Related]
8. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation.
Zwicky CS; Maddocks AB; Andersen N; Gribben JG
Blood; 1996 Nov; 88(9):3314-22. PubMed ID: 8896395
[TBL] [Abstract][Full Text] [Related]
9. Analysis of immunoglobulin H gene rearrangement by polymerase chain reaction in primary central nervous system lymphoma.
Kros JM; Bagdi EK; Zheng P; Hop WC; Driesse MJ; Krenacs L; Dinjens WN
J Neurosurg; 2002 Dec; 97(6):1390-6. PubMed ID: 12507138
[TBL] [Abstract][Full Text] [Related]
10. Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma.
Shen DF; Zhuang Z; LeHoang P; Böni R; Zheng S; Nussenblatt RB; Chan CC
Ophthalmology; 1998 Sep; 105(9):1664-9. PubMed ID: 9754175
[TBL] [Abstract][Full Text] [Related]
11. Characterization of genomic alterations in primary central nervous system lymphomas.
Zorofchian S; El-Achi H; Yan Y; Esquenazi Y; Ballester LY
J Neurooncol; 2018 Dec; 140(3):509-517. PubMed ID: 30171453
[TBL] [Abstract][Full Text] [Related]
12. CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes.
Gleissner B; Siehl J; Korfel A; Reinhardt R; Thiel E
Neurology; 2002 Feb; 58(3):390-6. PubMed ID: 11839837
[TBL] [Abstract][Full Text] [Related]
13. Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes.
Jahnke K; Hummel M; Korfel A; Burmeister T; Kiewe P; Klasen HA; Müller HH; Stein H; Thiel E
J Clin Oncol; 2006 Oct; 24(29):4754-7. PubMed ID: 16966685
[TBL] [Abstract][Full Text] [Related]
14. Application of the Euro Clonality next-generation sequencing-based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial.
Genuardi E; Romano G; Beccuti M; Alessandria B; Mannina D; Califano C; Rota Scalabrini D; Cortelazzo S; Ladetto M; Ferrero S; Calogero RA; Cordero F
Br J Haematol; 2021 Jul; 194(2):378-381. PubMed ID: 34002365
[TBL] [Abstract][Full Text] [Related]
15. Clonal immunoglobulin heavy chain and T-cell receptor γ gene rearrangements in primary gastric lymphoma.
Shan GD; Hu FL; Yang M; Chen HT; Chen WG; Wang YG; Chen LH; Li YM; Xu GQ
World J Gastroenterol; 2013 Sep; 19(34):5727-31. PubMed ID: 24039368
[TBL] [Abstract][Full Text] [Related]
16. Better detection of Ig heavy chain and TCRγ gene rearrangement in plasma cell-free DNA from patients with non-Hodgkin Lymphoma.
Zhong L; Huang WF
Neoplasma; 2010; 57(6):507-11. PubMed ID: 20845988
[TBL] [Abstract][Full Text] [Related]
17. Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia.
Shin S; Hwang IS; Kim J; Lee KA; Lee ST; Choi JR
Ann Lab Med; 2017 Jul; 37(4):331-335. PubMed ID: 28445014
[TBL] [Abstract][Full Text] [Related]
18. [The clinical significance of Ig heavy chain and TCR gamma gene rearrangement detected in free DNA in plasma in patients with non-Hodgkin lymphoma].
Zhong L; Jia YQ; Meng WT; Tang Y; Ni X
Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):258-62. PubMed ID: 18843981
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma.
Fontanilles M; Marguet F; Bohers É; Viailly PJ; Dubois S; Bertrand P; Camus V; Mareschal S; Ruminy P; Maingonnat C; Lepretre S; Veresezan EL; Derrey S; Tilly H; Picquenot JM; Laquerrière A; Jardin F
Oncotarget; 2017 Jul; 8(29):48157-48168. PubMed ID: 28636991
[TBL] [Abstract][Full Text] [Related]
20. Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources.
Léonard BM; Hétu F; Busque L; Gyger M; Bélanger R; Perreault C; Roy DC
Blood; 1998 Jan; 91(1):331-9. PubMed ID: 9414302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
